Role of adenosine-guided pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: a meta-analysis

Europace. 2017 Apr 1;19(4):552-559. doi: 10.1093/europace/euw201.

Abstract

Aims: Adenosine had been reported to unmask dormant conduction and thus identify pulmonary vein at risk of reconnection. However, the role of adjunctive adenosine infusion after pulmonary vein isolation (PVI) on long-term arrhythmia-free survival was still contentious. The purpose of the present meta-analysis was to assess the association of adenosine testing with long-term ablation success in patients with atrial fibrillation (AF) (i.e. freedom from AF recurrence).

Methods and results: We systematically searched the electronic databases and finally included 10 studies, with 1771 patients undergoing adenosine-guided PVI and 1787 patients undergoing conventional PVI. In comparison to conventional PVI alone, adenosine-guided PVI improved the arrhythmia-free survival by 17% during a median follow-up of 12 months [relative risk (RR): 1.17; 95% confidence interval (CI): 1.07 to 1.27; P = 0.014]. Patients undergoing adenosine-guided PVI had similar fluoroscopy time to those who undergoing conventional PVI [weighted mean difference (WMD): 1.76; 95% CI: -5.66 to 9.17; P = 0.64], despite longer procedure time (WMD: 20.6; 95% CI: 0.70 to 40.50; P = 0.042).

Conclusion: From the available data of clinical studies, adenosine-guided PVI was associated with an increased arrhythmia-free survival when compared with conventional PVI in patients undergoing catheter ablation for AF.

Keywords: Adenosine; Atrial fibrillation; Dormant conduction; Meta-analysis; Pulmonary vein isolation.

Publication types

  • Meta-Analysis

MeSH terms

  • Adenosine / administration & dosage*
  • Atrial Fibrillation / diagnosis*
  • Atrial Fibrillation / mortality
  • Atrial Fibrillation / surgery*
  • Catheter Ablation / methods*
  • Catheter Ablation / mortality
  • Catheter Ablation / statistics & numerical data*
  • Disease-Free Survival
  • Evidence-Based Medicine
  • Female
  • Heart Conduction System / drug effects
  • Heart Conduction System / surgery
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Pulmonary Veins / drug effects*
  • Pulmonary Veins / surgery*
  • Risk Factors
  • Survival Rate
  • Treatment Outcome

Substances

  • Adenosine